The Fort Worth Press - AMC Health Appoints Sol Babani and Symbiosis Advisors as Strategic Advisor to Its Decentralized Clinical Trial Service Line

USD -
AED 3.672504
AFN 66.503991
ALL 80.629676
AMD 365.091035
AOA 917.000367
ARS 1491.937897
AUD 1.417435
AWG 1.80125
AZN 1.70397
BAM 1.691649
BBD 2.00813
BDT 123.418242
BHD 0.375989
BIF 2985.079791
BMD 1
BND 1.277602
BOB 11.849673
BRL 5.083304
BSD 0.997016
BTN 94.875232
BWP 13.457596
BYN 2.968819
BYR 19600
BZD 2.00519
CAD 1.39545
CDF 2262.50392
CHF 0.80949
CLF 0.023206
CLP 913.315746
CNY 6.747604
CNH 6.743285
COP 3142.844787
CRC 453.228387
CUC 1
CUP 26.5
CVE 95.372573
CZK 20.982104
DJF 177.546166
DKK 6.46804
DOP 58.20179
DZD 132.308956
EGP 49.631449
ERN 15
ETB 160.923669
EUR 0.86495
FJD 2.20855
FKP 0.74148
GBP 0.742583
GEL 2.610391
GGP 0.74148
GHS 11.700039
GIP 0.74148
GMD 73.503851
GNF 8756.649224
GTQ 7.607144
GYD 208.588851
HKD 7.84315
HNL 26.723176
HRK 6.518804
HTG 130.363707
HUF 314.060388
IDR 17801
ILS 2.99985
IMP 0.74148
INR 95.210504
IQD 1306.058902
IRR 1375550.000352
ISK 123.340386
JEP 0.74148
JMD 158.335856
JOD 0.70904
JPY 157.80604
KES 129.014401
KGS 87.450384
KHR 4049.647537
KMF 426.00035
KRW 1407.860383
KWD 0.30866
KYD 0.830861
KZT 467.275008
LAK 22510.919863
LBP 89282.792025
LKR 334.420274
LRD 179.959348
LSL 16.197552
LTL 2.95274
LVL 0.60489
LYD 6.341738
MAD 9.29222
MDL 17.337716
MGA 4254.638239
MKD 53.215413
MMK 2099.549369
MNT 3595.852714
MOP 8.056654
MRU 40.080439
MUR 47.070378
MVR 15.450378
MWK 1728.841413
MXN 17.13645
MYR 4.090104
MZN 63.905039
NAD 16.197552
NGN 1364.860377
NIO 36.690741
NOK 9.51237
NPR 151.800372
NZD 1.701115
OMR 0.382693
PAB 0.997016
PEN 3.376465
PGK 4.406003
PHP 60.705038
PKR 276.796523
PLN 3.719205
PYG 5928.296501
QAR 3.644596
RON 4.536304
RSD 101.492021
RUB 81.598409
RWF 1466.072741
SAR 3.755591
SBD 8.065696
SCR 14.449077
SDG 600.503676
SEK 9.480804
SGD 1.278038
SLE 24.603667
SOS 569.822255
SRD 37.866504
STD 20697.981008
STN 21.191022
SVC 8.723782
SZL 16.194265
THB 33.050369
TJS 9.197509
TMT 3.51
TND 2.929032
TRY 47.697504
TTD 6.757774
TWD 32.250604
TZS 2639.622886
UAH 44.653894
UGX 3714.050945
UYU 40.133201
UZS 11924.058297
VES 755.762404
VND 26204.5
VUV 118.557141
WST 2.733716
XAF 567.363231
XAG 0.015731
XAU 0.00023
XCD 2.70255
XCG 1.796912
XDR 0.705618
XOF 567.363231
XPF 103.152705
YER 238.403589
ZAR 16.14632
ZMK 9001.203584
ZMW 18.818492
ZWL 321.999592
  • CMSC

    0.0240

    21.744

    +0.11%

  • CMSD

    -0.1600

    21.82

    -0.73%

  • BCC

    2.3400

    86.6

    +2.7%

  • JRI

    0.1500

    12.81

    +1.17%

  • BCE

    -0.0200

    22.75

    -0.09%

  • RELX

    0.0485

    35.52

    +0.14%

  • RIO

    1.4500

    101.1

    +1.43%

  • GSK

    0.7900

    52.96

    +1.49%

  • RBGPF

    0.7600

    70.5

    +1.08%

  • RYCEF

    0.2300

    20.85

    +1.1%

  • NGG

    0.4700

    80.88

    +0.58%

  • VOD

    0.1900

    16.19

    +1.17%

  • BP

    -0.6000

    41.63

    -1.44%

  • BTI

    0.6000

    59.33

    +1.01%

  • AZN

    1.4100

    161.42

    +0.87%

AMC Health Appoints Sol Babani and Symbiosis Advisors as Strategic Advisor to Its Decentralized Clinical Trial Service Line
AMC Health Appoints Sol Babani and Symbiosis Advisors as Strategic Advisor to Its Decentralized Clinical Trial Service Line

AMC Health Appoints Sol Babani and Symbiosis Advisors as Strategic Advisor to Its Decentralized Clinical Trial Service Line

Industry veteran brings deep CRO and biopharma expertise from ICON, PRA Health Sciences, and Covance to accelerate growth and operationalization of AMC Health's DCT platform

Text size:

NEW YORK CITY, NY / ACCESS Newswire / May 5, 2026 / AMC Health today announced the appointment of Sol Babani, Founder and CEO of Symbiosis Advisors, as Strategic Advisor to its newly established Decentralized Clinical Trial (DCT) service line. Babani will work closely with CEO Nesim Bildirici and Keith Tode, Executive Vice President of Decentralized Clinical Trials, to grow and operationalize AMC Health's DCT platform as it expands its modular operating partner offering to biopharmaceutical sponsors, medical device companies, and CROs.

"As we move into active commercialization of our DCT service line, Sol's depth across the CRO and sponsor landscape is exactly the strategic muscle we need. He's not just advising, he's helping us build the commercial engine."

- Nesim Bildirici, Chief Executive Officer, AMC Health

ABOUT SOL BABANI & SYMBIOSIS ADVISORS

Sol Babani is the Founder of Symbiosis Advisors, a strategic advisory firm serving start-up and mid-market healthcare and life sciences companies. Symbiosis specializes in positioning organizations for growth, preparing them for the scrutiny of transactions, and building strategic partnerships and alliances - embedding directly within client leadership teams to align expertise with vision.

Babani brings decades of senior CRO and biopharma industry experience, having served as Senior Vice President at ICON Biotech, Senior Vice President of Drug Development at PRA Health Sciences, and Vice President of Biopharma Solutions at Covance. His career spans pharma, biotech, and medical device, giving AMC Health access to one of the most experienced commercial and operational minds in the clinical research industry.

"What caught my attention about AMC Health is how few companies in this space have both the clinical infrastructure and the operational maturity to serve as a true operating partner. That combination is rare, and it's exactly what the sponsor and CRO market is looking for right now."

- Sol Babani, Founder, Symbiosis Advisors & Strategic Advisor, AMC Health DCT

A STRATEGIC PARTNERSHIP BUILT FOR GROWTH

The appointment of Babani and Symbiosis Advisors reflects AMC Health's commitment to building its DCT service line with the commercial rigor and strategic infrastructure required to compete at the highest level of the clinical research market. With Babani's network and expertise in CRO and sponsor partnerships, AMC Health is positioned to accelerate the adoption of its modular DCT operating model across the life sciences industry.

ABOUT AMC HEALTH

AMC Health is a remote patient monitoring and decentralized clinical trial services company with a proven track record supporting the U.S. Department of Veterans Affairs. Through its DCT Platform, AMC Health delivers modular operating partner services to biopharmaceutical sponsors, medical device companies, and CROs across fully remote and hybrid clinical study designs. For more information, visit www.amchealth.com.

ABOUT SYMBIOSIS ADVISORS

Symbiosis Advisors is a strategic advisory firm helping start-up and mid-market healthcare and life sciences companies position themselves for success, prepare for transactions, and build top-tier strategic partnerships and alliances. Symbiosis works side by side with client leadership teams, embedding expertise directly within the organization to build stronger, more valuable companies. For more information, visit www.symbiosisadvisors.com.

Contact Information

Gary Feiner
Director of Marketing
[email protected]
(877) 262-2240

SOURCE: AMC Health



View the original press release on ACCESS Newswire

T.M.Dan--TFWP